diquas ophthalmic solution 3%
santen pharma malaysia sdn. bhd. - diquafosol sodium -
cosopt-s ophthalmic solution
santen pharmaceutical asia pte. ltd. - dorzolamide hydrochloride 22.26mg/ml eqv. dorzolamide base; timolol maleate 6.83mg/ml eqv. timolol base - solution, sterile - dorzolamide hydrochloride 22.26mg/ml eqv. dorzolamide base 20mg/ml; timolol maleate 6.83mg/ml eqv. timolol base 5mg/ml
trusopt ophthalmic solution 2%
santen pharmaceutical asia pte. ltd. - dorzolamide hcl eqv dorzolamide - solution - dorzolamide hcl eqv dorzolamide 2%
eybelis ophthalmic solution 0.002%
santen pharma malaysia sdn. bhd. - omidenepag isopropyl -
saflutan 15 micrograms/ml eye drops, solution, single-dose container
santen oy niittyhaankatu 20, 33720 tampere, finland - tafluprost - eye drops, solution - tafluprost 15 µg/ml - ophthalmologicals
saflutan 15 micrograms/ml, eye drops, solution in single-dose container
santen oy - tafluprost - eye drops, solution in single-dose container - 15 microgram(s)/millilitre - prostaglandin analogues1); tafluprost - antiglaucoma preparations and miotics, prostaglandin analogues - as monotherapy in patients: who would benefit from preservative free eye drops insufficiently responsive to first line therapy intolerant or contra-indicated to first line therapy. as adjunctive therapy to beta-blockers.
timoptol 0.25% w/v eye drops, solution
santen oy - timolol base - eye drops, solution - 0.25 percent weight/volume - beta blocking agents1); timolol - it is a beta-adrenoreceptor blocking agent used topically in the reduction of elevated intra-ocular pressure in various conditions including the following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma.
timoptol 0.5% w/v eye drops, solution
santen oy - timolol base - eye drops, solution - 0.5 percent weight/volume - beta blocking agents1); timolol - it is a beta-adrenoreceptor blocking agent used topically in the reduction of elevated intra-ocular pressure in various conditions including the following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma.
trusopt 20 mg/ml eye drops, solution
santen oy - dorzolamide hydrochloride - eye drops, solution - 20 milligram(s)/millilitre - dorzolamide - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors, dorzolamide - it is indicated: as adjunctive therapy to beta-blockers, as monotherapy in patients unresponsive to beta-blockers or in whom beta-blockers are contraindicated, in the treatment of elevated intra-ocular pressure in: ocular hypertension, open-angle glaucoma, pseudoexfoliative glaucoma.
trusopt preservative-free 20 mg/ml eye drops, solution in single-dose container
santen oy - dorzolamide - eye drops, solution in single-dose container - 20 milligram(s)/millilitre - carbonic anhydrase inhibitors; dorzolamide - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors, dorzolamide - it l is indicated: as adjunctive therapy to beta-blockers; as monotherapy in patients unresponsive to beta-blockers or in whom beta-blockers are contraindicated; in the treatment of elevated intra-ocular pressure in: ocular hypertension; open-angle glaucoma; pseudoexfoliative glaucoma.